Flyvbjerg A - Search Results

1

Plasma adiponectin before and after kidney transplantation.

Idorn T, Hornum M, Bjerre M, Jørgensen KA, Nielsen FT, Hansen JM, Flyvbjerg A, Feldt-Rasmussen B. Idorn T, et al. Among authors: flyvbjerg a. Transpl Int. 2012 Nov;25(11):1194-203. doi: 10.1111/j.1432-2277.2012.01560.x. Epub 2012 Sep 21. Transpl Int. 2012. PMID: 22994569 Free article.

2

Impaired vascular function during short-term poor glycaemic control in Type 1 diabetic patients.

Sørensen VR, Mathiesen ER, Clausen P, Flyvbjerg A, Feldt-Rasmussen B. Sørensen VR, et al. Among authors: flyvbjerg a. Diabet Med. 2005 Jul;22(7):871-6. doi: 10.1111/j.1464-5491.2005.01543.x. Diabet Med. 2005. PMID: 15975101

3

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.

Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P. Kistorp C, et al. Among authors: flyvbjerg a. Circulation. 2005 Sep 20;112(12):1756-62. doi: 10.1161/CIRCULATIONAHA.104.530972. Epub 2005 Sep 12. Circulation. 2005. PMID: 16157772

4

Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes.

Højlund K, Frystyk J, Levin K, Flyvbjerg A, Wojtaszewski JF, Beck-Nielsen H. Højlund K, et al. Among authors: flyvbjerg a. Diabetologia. 2006 Jun;49(6):1283-91. doi: 10.1007/s00125-006-0240-5. Epub 2006 Apr 12. Diabetologia. 2006. PMID: 16609880 Free article.

5

Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.

Jorsal A, Tarnow L, Frystyk J, Lajer M, Flyvbjerg A, Parving HH, Vionnet N, Rossing P. Jorsal A, et al. Among authors: flyvbjerg a. Kidney Int. 2008 Sep;74(5):649-54. doi: 10.1038/ki.2008.201. Epub 2008 May 21. Kidney Int. 2008. PMID: 18496510 Free article.

6

Elevated levels of high-molecular-weight adiponectin in type 1 diabetes.

Leth H, Andersen KK, Frystyk J, Tarnow L, Rossing P, Parving HH, Flyvbjerg A. Leth H, et al. Among authors: flyvbjerg a. J Clin Endocrinol Metab. 2008 Aug;93(8):3186-91. doi: 10.1210/jc.2008-0360. Epub 2008 May 27. J Clin Endocrinol Metab. 2008. PMID: 18505763

7

Complement activation and cardiovascular disease.

Bjerre M, Hansen TK, Flyvbjerg A. Bjerre M, et al. Among authors: flyvbjerg a. Horm Metab Res. 2008 Sep;40(9):626-34. doi: 10.1055/s-0028-1083786. Epub 2008 Sep 15. Horm Metab Res. 2008. PMID: 18792874 Review.

8

Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention.

Haahr-Pedersen S, Bjerre M, Flyvbjerg A, Mogelvang R, Dominquez H, Hansen TK, Galatius S, Bech J, Madsen JK, Søgaard P, Jensen JS. Haahr-Pedersen S, et al. Among authors: flyvbjerg a. J Invasive Cardiol. 2009 Jan;21(1):13-9. J Invasive Cardiol. 2009. PMID: 19126922

9

Simultaneous detection of porcine cytokines by multiplex analysis: development of magnetic bioplex assay.

Bjerre M, Hansen TK, Flyvbjerg A, Tønnesen E. Bjerre M, et al. Among authors: flyvbjerg a. Vet Immunol Immunopathol. 2009 Jul 15;130(1-2):53-8. doi: 10.1016/j.vetimm.2009.01.007. Epub 2009 Feb 23. Vet Immunol Immunopathol. 2009. PMID: 19230983

10

Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study.

Asferg C, Møgelvang R, Flyvbjerg A, Frystyk J, Jensen JS, Marott JL, Appleyard M, Jensen GB, Jeppesen J. Asferg C, et al. Among authors: flyvbjerg a. Am J Hypertens. 2010 Mar;23(3):327-33. doi: 10.1038/ajh.2009.244. Epub 2009 Dec 17. Am J Hypertens. 2010. PMID: 20019673

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

541 results

Search Page